The interactome of the N-terminus of band 3 regulates red blood cell metabolism and storage quality.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 24 12 2020
pubmed: 14 5 2021
medline: 1 4 2022
entrez: 13 5 2021
Statut: epublish

Résumé

Band 3 (anion exchanger 1; AE1) is the most abundant membrane protein in red blood cells, which in turn are the most abundant cells in the human body. A compelling model posits that, at high oxygen saturation, the N-terminal cytosolic domain of AE1 binds to and inhibits glycolytic enzymes, thus diverting metabolic fluxes to the pentose phosphate pathway to generate reducing equivalents. Dysfunction of this mechanism occurs during red blood cell aging or storage under blood bank conditions, suggesting a role for AE1 in the regulation of the quality of stored blood and efficacy of transfusion, a life-saving intervention for millions of recipients worldwide. Here we leveraged two murine models carrying genetic ablations of AE1 to provide mechanistic evidence of the role of this protein in the regulation of erythrocyte metabolism and storage quality. Metabolic observations in mice recapitulated those in a human subject lacking expression of AE11-11 (band 3 Neapolis), while common polymorphisms in the region coding for AE11-56 correlate with increased susceptibility to osmotic hemolysis in healthy blood donors. Through thermal proteome profiling and crosslinking proteomics, we provide a map of the red blood cell interactome, with a focus on AE11-56 and validate recombinant AE1 interactions with glyceraldehyde 3-phosphate dehydrogenase. As a proof-of-principle and to provide further mechanistic evidence of the role of AE1 in the regulation of redox homeo stasis of stored red blood cells, we show that incubation with a cell-penetrating AE11-56 peptide can rescue the metabolic defect in glutathione recycling and boost post-transfusion recovery of stored red blood cells from healthy human donors and genetically ablated mice.

Identifiants

pubmed: 33979990
doi: 10.3324/haematol.2020.278252
pmc: PMC8561282
doi:

Substances chimiques

Anion Exchange Protein 1, Erythrocyte 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2971-2985

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL146442
Pays : United States
Organisme : NIGMS NIH HHS
ID : RM1 GM131968
Pays : United States
Organisme : NIH HHS
ID : S10 OD021641
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148151
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21 HL150032
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149714
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM113838
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

J Cell Mol Med. 2007 Jan-Feb;11(1):148-55
pubmed: 17367509
J Proteome Res. 2020 Nov 6;19(11):4455-4469
pubmed: 33103907
Biochemistry. 1998 Jan 20;37(3):867-77
pubmed: 9454576
Blood. 2016 Sep 22;128(12):e32-42
pubmed: 27405778
Free Radic Biol Med. 2013 Feb;55:27-35
pubmed: 23123411
Nat Commun. 2016 Jul 15;7:12086
pubmed: 27417539
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18515-20
pubmed: 19846781
J Proteome Res. 2014 Apr 4;13(4):2028-44
pubmed: 24555563
J Proteome Res. 2016 Oct 7;15(10):3883-3895
pubmed: 27646145
Br J Haematol. 1997 Jan;96(1):70-6
pubmed: 9012689
Methods Mol Biol. 2019;1978:13-26
pubmed: 31119654
Am J Hematol. 2018 May;93(5):E110-E112
pubmed: 29352741
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Dec;26(6):1826-1830
pubmed: 30501728
Nat Protoc. 2015 Oct;10(10):1567-93
pubmed: 26379230
Blood. 2005 Dec 15;106(13):4359-66
pubmed: 16118313
Biochim Biophys Acta. 1998 Aug 14;1404(1-2):153-60
pubmed: 9714784
Haematologica. 2012 Jan;97(1):107-15
pubmed: 21993682
Free Radic Biol Med. 2016 Jul;96:152-65
pubmed: 27094493
Transfusion. 2019 Jan;59(1):101-111
pubmed: 30456907
Blood Adv. 2017 Jun 27;1(15):1132-1141
pubmed: 29034365
Transfusion. 2009 Jul;49(7):1435-42
pubmed: 19389033
Blood Transfus. 2019 Jan;17(1):27-52
pubmed: 30653459
Haematologica. 2016 May;101(5):578-86
pubmed: 26921359
J Clin Invest. 2020 May 1;130(5):2270-2285
pubmed: 31961822
Blood Transfus. 2010 Jun;8 Suppl 3:s48-52
pubmed: 20606749
Transfusion. 1997 Nov-Dec;37(11-12):1179-83
pubmed: 9426643
Blood. 2008 Jan 15;111(2):932-8
pubmed: 17942752
J Proteome Res. 2017 Aug 4;16(8):2752-2761
pubmed: 28689405
Blood. 2000 Nov 1;96(9):2925-33
pubmed: 11049968
Biochem J. 2006 Nov 15;400(1):143-51
pubmed: 16836485
J Biol Chem. 2013 Jan 11;288(2):848-58
pubmed: 23150667
Oxid Med Cell Longev. 2016;2016:6051093
pubmed: 27034738
J Proteome Res. 2010 Jan;9(1):144-63
pubmed: 19886704
Blood Adv. 2019 Aug 13;3(15):2272-2285
pubmed: 31350307
Blood Transfus. 2010 Jun;8 Suppl 3:s53-8
pubmed: 20606750
FASEB J. 2009 Sep;23(9):3159-70
pubmed: 19417084
Biochemistry. 2012 Apr 17;51(15):3264-72
pubmed: 22452706
Nat Commun. 2017 Oct 19;8(1):1035
pubmed: 29051543
Blood. 2016 Dec 8;128(23):2708-2716
pubmed: 27688804
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31581149
Haematologica. 2021 May 01;106(5):1290-1302
pubmed: 32241843
FEBS Lett. 1996 Jul 15;390(1):25-8
pubmed: 8706822
Science. 1985 Feb 1;227(4686):531-3
pubmed: 2578228
Br J Haematol. 1967 Sep;13(5):665-78
pubmed: 6050859
Blood Transfus. 2019 Jul;17(4):281-288
pubmed: 31184577
Transfusion. 2018 Dec;58(12):2978-2991
pubmed: 30312994
Front Physiol. 2018 May 04;9:421
pubmed: 29780325
Transfusion. 2000 Mar;40(3):353-60
pubmed: 10738039
Blood Transfus. 2017 Mar;15(2):182-187
pubmed: 28263177
Cell Death Dis. 2017 May 25;8(5):e2812
pubmed: 28542146
Methods Mol Biol. 2019;1978:121-135
pubmed: 31119660
Biochim Biophys Acta. 2002 Feb 10;1559(1):43-55
pubmed: 11825587
Beilstein J Nanotechnol. 2020 Jan 9;11:101-123
pubmed: 31976201
Blood Transfus. 2012 May;10 Suppl 2:s55-62
pubmed: 22890269

Auteurs

Aaron Issaian (A)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO.

Ariel Hay (A)

University of Virginia, Charlottesville, VA.

Monika Dzieciatkowska (M)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO.

Domenico Roberti (D)

Università della Campania "L. Vanvitelli", Naples.

Silverio Perrotta (S)

Università della Campania "L. Vanvitelli", Naples.

Zsuzsanna Darula (Z)

Laboratory of Proteomics Research, Biological Research Center, H-6701 Szeged.

Jasmina Redzic (J)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO.

Micheal P Busch (MP)

Vitalant Research Institute, San Francisco, CA.

Grier P Page (GP)

RTI International, Pittsburgh, PA.

Stephen C Rogers (SC)

University of Maryland, Baltimore, MD.

Allan Doctor (A)

University of Maryland, Baltimore, MD.

Kirk C Hansen (KC)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO.

Elan Z Eisenmesser (EZ)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO.

James C Zimring (JC)

University of Virginia, Charlottesville, VA. jcz2k@virginia.edu.

Angelo D'Alessandro (A)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO. angelo.dalessandro@ucdenver.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH